Bukwang Phenytoin Capsule 100 mg

Adult dosage

The dose should be adjusted according to the severity of seizures and the patient's tolerance; measure serum concentrations if necessary. This drug must not be administered once daily and must be given in divided doses. 1. Adults: Administer 100 mg of phenytoin orally 3 times daily; the maintenance dose is 300 ～ 400 mg of this drug in divided doses. The dose may be increased up to 600 mg daily. The dose may be adjusted appropriately according to age and symptoms. (Injection) 1. Status epilepticus or seizures that cannot be controlled with oral administration Adults: Slowly administer 125 ～ 250 mg of phenytoin sodium by intravenous injection at a rate not exceeding 50 mg/min. If seizures cannot be controlled with the above dose, administer an additional 100 ～ 150 mg of this drug after 30 minutes or consider other treatment. When convulsions have ceased and consciousness has returned following administration of this drug, switch to oral administration. 2. Digoxin-induced arrhythmias for which first-line treatment is ineffective Adults: Administer an initial dose of 3.5 ～ 5 mg/kg of body weight of phenytoin sodium by intravenous injection. Repeat once if necessary. This drug should be administered slowly by intravenous injection at a steady rate not exceeding 50 mg/min. The dose may be adjusted appropriately according to age and symptoms.

Children's dosage

Children: Administer 5 mg/kg of body weight of phenytoin in 2 ～ 3 divided doses; the maintenance dose is 4 ～ 8 mg/kg of body weight daily of this drug in divided doses. The daily dose may be increased up to 300 mg.

This drug is used for the treatment of epilepsy; therefore, patients taking it should be closely monitored for suicidal thoughts or behaviors and depression, which may affect mental health. When administered as an injectable, inflammation or skin changes at the injection site may occur, and in severe cases, tissue necrosis can happen. The injection site should be carefully checked, and appropriate injection techniques must be followed. Patients with allergies to this medication or severe blood disorders, as well as certain heart diseases, should not take it, and interactions may occur when combined with specific medications, so consultation with healthcare professionals is necessary. Patients with impaired liver or kidney function, hypothyroidism, or diabetes should exercise greater caution when using this medication, and if serious rashes or hypersensitivity reactions occur, they should stop taking it immediately and consult a doctor. This drug can cause various side effects, including dizziness, movement disorders, mental confusion, skin rashes, blood irregularities, and liver dysfunction, requiring regular examinations. Drowsiness or decreased concentration may occur during treatment, so it is advisable to avoid driving or operating hazardous machinery. During pregnancy, it should be avoided as it may pose risks to the fetus, and women of childbearing age should consult a doctor when planning to become pregnant and use effective contraception. Elderly patients may have reduced physical function, so starting with a low dose and gradually adjusting the dose is recommended, and discontinuation should also involve a slow tapering off. In the case of overdose, serious toxicity symptoms may occur, requiring immediate emergency treatment, and should be kept out of reach of children in a safe place. It is important to conduct regular health check-ups, including liver, kidney, and blood tests, to identify and manage abnormal signs early during the course of this medication.

suicidal impulses, suicidal behavior, depression, abnormal changes in mood and behavior, soft tissue irritation, inflammatory response, extravascular leakage, edema, skin discoloration, pain in the area distal to the injection site, necrosis, skin shedding, pain at the injection site, abscess, involuntary movements, abnormal movements, chorea, dystonia, neuropathy, dizziness, ataxia, mental confusion, dysarthria, insomnia, neurohyperesthesia, decreased attention, decreased concentration, reduced reflex motor ability, headache, fatigue, ataxia, tremor, sensory peripheral polyneuropathy, interstitial pneumonia, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, systemic lupus erythematosus-like symptoms, urticaria, drug hypersensitivity reactions, eosinophilia, fever, lymphadenopathy, facial edema, hepatitis, nephritis, hematological disorders, myocarditis, myositis, scarlet fever-like rash, measles-like rash, pure red cell aplasia, thrombocytopenia, leukopenia, granulocytopenia, agranulocytosis, pancytopenia, erythrocytosis, polycythemia vera, aplastic anemia, monocytic leukemia, hemolytic anemia, lymph node enlargement, lymphoma, pseudolymphoma, Hodgkin's disease, toxic hepatitis, jaundice, proteinuria, diplopia, ophthalmoplegia, visual impairment, cataract, gingival hyperplasia, facial ataxia, hirsutism, lip swelling, Peyronie's disease, nausea, vomiting, constipation, nodular periartritis, polyarthritis, hyperglycemia, fever, abnormal thyroid function test results, decreased serum folate levels, thirst, vascular pain, cardiovascular collapse, cardiac arrest, ventricular fibrillation, respiratory arrest, tonic seizure, decreased bone density, osteopenia, osteoporosis, fracture, nystagmus, speech impairment, severe tension hyperactivity, somnolence, coma, hypotension, respiratory disorders, vascular suppression, abnormal serum immunoglobulin, cerebellar atrophy

This medication should be stored in a sealed container to protect it from exposure to air and light. This helps maintain its effectiveness for a longer period.

Appearance

A white powder in a white capsule.

Package unit

100 capsules/bottle, 500 capsules/bottle